Ketamine/xylazine anesthesia alters [11C]MNPA binding to dopamine D2 receptors and response to methamphetamine challenge in monkey brain

Synapse

Volumn 63, Issue 6, 2009, Pages 534-537

  Ohba, Hiroyuki ^a   Harada, Norihiro ^a   Nishiyama, Shingo ^a   Kakiuchi, Takeharu ^a   Tsukada, Hideo ^a  

^a CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

11C MNPA; Ketamine; Monkey brain; PET

Indexed keywords

2 METHOXY N PROPYLNORAPOMORPHINE H 3; DOPAMINE 2 RECEPTOR; KETAMINE; METHAMPHETAMINE; RADIOLIGAND; UNCLASSIFIED DRUG; XYLAZINE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CEREBELLUM; CONSCIOUSNESS; CONTROLLED STUDY; CORPUS STRIATUM; MACACA; MALE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADRENERGIC ALPHA-AGONISTS; ANESTHETICS, DISSOCIATIVE; ANIMALS; APOMORPHINE; BINDING, COMPETITIVE; BRAIN; BRAIN CHEMISTRY; CARBON RADIOISOTOPES; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; KETAMINE; MACACA MULATTA; MALE; METHAMPHETAMINE; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION; XYLAZINE;

EID: 66149110767     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20632     Document Type: Article

References (27)

1. Adams BW, Bradberry CW, Moghaddam B. 2002. NMDA antagonist effects on striatal dopamine release: Microdialysis studies in awake monkeys. Synapse 43:12-18.
2. 125I]-N-(p-amino-phenethl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of rat pituitary gland: a thermodynamic study. Mol Pharmacol 33:163-169.
3. Chaparro-Huerta V, Beas-Zarate C, Guerrero MU, Feria-Velasco A. 1997. Nitric oxide involvement in regulating the dopamine transport in the striatum of rat brain. Neurochem Int 31:607-616.
4. Donzanti BA, Uretsky NJ. 1984. Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens. Naunyn-Schmied Arch Pharmacol 325:1-7.
5. 11C]MNPA in cynomolgus monkey. Nucl Med Biol 32:353-360.
6. Garthwaite J, Charles SL, Cross-Williams R. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388.
7. 18F]fluoro-ethyl) nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain. Synapse 54:37-45.
8. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096-1112.
9. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539.
10. Kilpatrick GJ, Tayar N El, Van de Waterbeemd H, Jenner P, Testa B, CD Marsden CD. 1986. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors. Mol Pharmacol 30:226-234.
11. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20:423-451. (Pubitemid 30164887)
12. Leviel V, Gobert A, Guibert B. 1990. The glutamate-mediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function. Neuroscience 39:305-312.
13. 2 receptor antagonist radiotracer [11C]raclopride. Synapse 52:188-208.
14. Raffa RB, Ortegón ME, Robisch DM, Martin GE. 1989. In vivo demonstration of the enhancement of MK-801 by L-glutamate. Life Sci 44:1593-1599.
15. Schmidt WJ. 1986. Intrastriatal injection of Dl-2-amino-5- phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90:123-130.
16. 11C]raclopride. Synapse 59:260-269.
17. 11C]raclopride?: PET studies combined with microdialysis in conscious monkeys. Brain Res 841:160-169.
18. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, Nakanishi S. 1999b. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res 849:85-96.
19. 11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis. Synapse 37:95-103.
20. 2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: PET studies with microdialysis in the conscious monkey brain. J Neurosci 20:7067-7073.
21. 1 receptors: PET studies in the conscious monkey brain. Synapse 42:258-265.
22. 11C]β-CIT-FE in the monkey brain. Synapse 42:273-280.
23. 11C]raclopride binding in unanesthetized monkeys. Synapse 45:207-212.
24. 11C]DOPA: PET studies in the conscious monkey brain. Synapse 57:116-119.
25. Watanabe M, Okada H, Shimizu K, Omura T, Yoshikawa E, Kosugi T, Mori S, Yamashita T. 1997. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans Nucl Sci 44:1277-1282.
26. Willetts J, Balster RL, Leander JD. 1990. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428.
27. Yamamura T, Harada K, Okamura A, Kenmothsu O. 1990. Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology 72:704-710.